Literature DB >> 8100714

Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells.

J C Louis1, M O Revel, J Zwiller.   

Abstract

Soluble guanylate cyclase was found to be phosphorylated by protein kinase C in intact PC12 pheochromocytoma cells. The phosphate incorporation into guanylate cyclase upon addition of phorbol 12-O-myristate 13-acetate (PMA) to PC12 cells in culture coincided with an increased intracellular cGMP level. A strong correlation between phosphate incorporation into guanylate cyclase and increased cGMP level was also observed by time-course and dose-response studies of the PMA effect, as well as when cells were treated with various phorbol esters and diacylglycerols or with various protein kinase C inhibitors. The cAMP system and the presence of extracellular Ca2+ were found not to be involved in guanylate cyclase phosphorylation. The phosphorylation and activation of guanylate cyclase by protein kinase C represent a possible mechanism whereby agonist-stimulation of receptors coupled to phosphoinositide hydrolysis induces cGMP synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100714     DOI: 10.1016/0167-4889(93)90126-a

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.

Authors:  Pilar Monfort; María-Dolores Muñoz; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

3.  Phosphorylation and activation of the intestinal guanylyl cyclase receptor for Escherichia coli heat-stable toxin by protein kinase C.

Authors:  J K Crane; K L Shanks
Journal:  Mol Cell Biochem       Date:  1996-12-20       Impact factor: 3.396

Review 4.  Altered modulation of soluble guanylate cyclase by nitric oxide in patients with liver disease.

Authors:  R Corbalán; C Montoliu; M D Miñana; J A Del Olmo; M A Serra; L Aparisi; J M Rodrigo; V Felipo
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

5.  Eclosion hormone-stimulated cGMP levels in the central nervous system of Manduca sexta: inhibition by lipid metabolism blockers, increase in inositol(1,4,5)trisphosphate and further evidence against the involvement of nitric oxide.

Authors:  D B Morton; P J Simpson
Journal:  J Comp Physiol B       Date:  1995       Impact factor: 2.200

6.  Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells.

Authors:  Jenelle D Jones; Skyla T Carney; Kent E Vrana; Derek C Norford; Allyn C Howlett
Journal:  Neuropharmacology       Date:  2007-07-12       Impact factor: 5.250

7.  Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells.

Authors:  H Shindo; T P Thomas; D D Larkin; A K Karihaloo; H Inada; T Onaya; M J Stevens; D A Greene
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

8.  Guanosine stimulates neurite outgrowth in PC12 cells via activation of heme oxygenase and cyclic GMP.

Authors:  Christian Bau; Pamela J Middlemiss; Shaun Hindley; Shucui Jiang; Renata Ciccarelli; Francesco Caciagli; Patrizia Diiorio; Eva S Werstiuk; Michel P Rathbone
Journal:  Purinergic Signal       Date:  2005-03-07       Impact factor: 3.765

Review 9.  Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow.

Authors:  Natasha M Rogers; Franziska Seeger; Elsa D Garcin; David D Roberts; Jeffrey S Isenberg
Journal:  Front Physiol       Date:  2014-04-04       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.